OpiSafe

A recent study in JAMA found that youth given opioid prescriptions, even at short and low doses, are at risk of persistent use. That’s one of the reasons why one of the top 10 pediatric hospitals in the nation uses OpiSafe to strengthen its opioid stewardship and assure the safety of young patients.

Trajectories of Opioid Use Following First Prescription in Opioid-Naive Youths This cohort study examines trajectories of opioid use among youths aged 10 to 21 years who had been prescribed opioids for the first time.

We're thrilled to see all the attention Don Stader, MD, our Medical Director of Emergency Medicine is receiving for his work with the Naloxone Project. Kudos!

Hospitals Give Out Doses of Antidote to Fight Opioid Crisis When doctors write a prescription for the life-saving antidote to an opioid overdose, patients only bother to fill them about 5% of the time.

Justice-involved individuals with opioid used isorder (OUD) are at greatest risk for overdose the first two weeks after incarceration. Until medication-assisted treatment (MAT) is more readily available to these individuals, we believe everyone with OUD leaving incarceration should receive Naloxone and OpiRescue. We’ve already begun to work with Colorado and other states on this important issue.

MAT Often Not an Option for Opioid Users in Justice System Medicaid expansion seems to have helped, but not a lot